Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Durell

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Food Management|March 10, 1988
Putting dietetic technicians to workM Durell
The Mount Sinai Journal of Medicine, New York|March 1, 1979
The New York State Medicaid Cost Containment Program: a case study and critiqueJ M Metsch, M Durell, G Niedziolka
Plos One|August 23, 2014
Atomoxetine effects on executive function as measured by the BRIEF--a in young adults with ADHD: a randomized, double-blind, placebo-controlled studyLenard A Adler, David B Clemow, David W Williams, et al.
Substance Abuse Treatment, Prevention, and Policy|July 29, 2008
Prevalence of nonmedical methamphetamine use in the United StatesTodd M Durell, Larry A Kroutil, Paul Crits-Christoph, et al.
International Clinical Psychopharmacology|December 18, 2010
Relationship between African-American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of AmericaElisabeth K Degenhardt, Jorge M Tamayo, Hassan H Jamal, et al.
Experimental and Clinical Psychopharmacology|June 8, 2006
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humansJoshua A Lile, William W Stoops, Todd M Durell, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 26, 2009
Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorderTodd M Durell, Andres J Pumariega, Eugenio M Rothe, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studiesMauricio Tohen, Michael Case, Madhukar H Trivedi, et al.
The American Journal on Addictions|October 21, 2010
Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged populationHimanshu P Upadhyaya, Larry A Kroutil, Deborah Deas, et al.
Clinical Therapeutics|January 31, 2012
Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysisLenard A Adler, Timothy Wilens, Shuyu Zhang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Food Management|March 10, 1988
Putting dietetic technicians to workM Durell
The Mount Sinai Journal of Medicine, New York|March 1, 1979
The New York State Medicaid Cost Containment Program: a case study and critiqueJ M Metsch, M Durell, G Niedziolka
Plos One|August 23, 2014
Atomoxetine effects on executive function as measured by the BRIEF--a in young adults with ADHD: a randomized, double-blind, placebo-controlled studyLenard A Adler, David B Clemow, David W Williams, et al.
Substance Abuse Treatment, Prevention, and Policy|July 29, 2008
Prevalence of nonmedical methamphetamine use in the United StatesTodd M Durell, Larry A Kroutil, Paul Crits-Christoph, et al.
International Clinical Psychopharmacology|December 18, 2010
Relationship between African-American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of AmericaElisabeth K Degenhardt, Jorge M Tamayo, Hassan H Jamal, et al.
Experimental and Clinical Psychopharmacology|June 8, 2006
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humansJoshua A Lile, William W Stoops, Todd M Durell, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 26, 2009
Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorderTodd M Durell, Andres J Pumariega, Eugenio M Rothe, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studiesMauricio Tohen, Michael Case, Madhukar H Trivedi, et al.
The American Journal on Addictions|October 21, 2010
Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged populationHimanshu P Upadhyaya, Larry A Kroutil, Deborah Deas, et al.
Clinical Therapeutics|January 31, 2012
Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysisLenard A Adler, Timothy Wilens, Shuyu Zhang, et al.
Pageof 2